Skip to content Skip to navigation

Press

Jun 11 2020 | Posted In: 20/20 Blog, Press
Palo Alto, CA — Despite progressively losing his vision to a genetic retinal degenerative disease, Michael Stone, an athlete and small business owner, is active, optimistic, and determined. He channels his energy into running and biking, teaming up with friends to guide him through these activities...
Jun 8 2020 | Posted In: 20/20 Blog, Press
Palo Alto, Ca — Genetic testing doesn’t always provide a diagnosis, so Vinit Mahajan M.D., Ph.D., associate professor of ophthalmology at Stanford University, has applied proteomics to better understand disease in his patients.  Proteomics is the large-scale analysis of protein expression, and for...
Sep 5 2019 | Posted In: 20/20 Blog, Press
Palo Alto, CA – The Stanford Ophthalmology Department highlighted its  clinical, surgical, and research achievements in its first annual report Vision Matters: Imagining the Future. In recent years, the department has grown dramatically doubling its faculty and clinical fellows. 
Jun 19 2019 | Posted In: 20/20 Blog, Press
Palo Alto, CA - Vinit Mahajan M.D., Ph.D., Stanford vitreoretinal surgeon and Vice Chair of Research in the department of ophthalmology, was recently featured in the article, “Precision Medicine Will Rely on Proteins, Not Just DNA,” written by MaryAnn Liebert for Genetic Engineering and...
Jun 9 2018 | Posted In: 20/20 Blog, Press
Los Angeles, CA — Vinit Mahajan was the 16th Straatsma Lecturer at UCLA’s Department of Ophthalmology Annual Seminar held at the Stein Eye Institute.     Dr. Mahajan’s lecture, “Personalized Proteomics Guide Diagnosis and Therapy of Eye Disease,” detailed the work he is doing at Stanford University...

Pages